BlueCrest Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

BlueCrest Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$561K	Buy
2018 Q4	–	Sell
2018 Q3	$296K	Buy
2018 Q1	–	Sell
2017 Q4	$575K	Sell
2017 Q3	$1.88M	Sell
2017 Q2	$1.3M	Buy
2016 Q1	–	Sell
2015 Q4	$420K	Buy